• Baicalin Restores Visual Plasticity in Adult Amblyopic Mice

  2026-08-03

  The reference study demonstrates that baicalin can reactivate ocular dominance plasticity and restore vision in adult mice with amblyopia, a condition previously considered refractory in adulthood. These findings introduce a viable pharmacological approach for adult amblyopia by targeting cortical inhibition and synaptic remodeling.

• AMG 487 and the CXCL10-CXCR3-LAMP1 Axis: Redefining Macropha

  2026-08-03

  Discover how AMG 487, a potent CXCR3 antagonist, reveals new dimensions in the regulation of macrophage polarization via the CXCL10-CXCR3-LAMP1 axis. This article delivers a deep scientific analysis and actionable insights for inflammation and translational immunology research.

• Sildenafil Citrate: Precision Tool for Native Membrane Prote

  2026-08-02

  Explore how Sildenafil Citrate empowers high-resolution, proteoform-specific research in native membrane environments. This in-depth analysis highlights novel methodological advances and practical assay insights for PDE5 inhibition, surpassing conventional vascular studies.

• Protein A/G Magnetic Co-IP/IP Kit: Precision in Protein Comp

  2026-08-01

  The Protein A/G Magnetic Co-IP/IP Kit leverages recombinant Protein A/G magnetic beads to deliver rapid, high-fidelity isolation of protein complexes for advanced interaction analysis. Its streamlined workflow and robust specificity set new standards for reproducibility in co-immunoprecipitation and antibody purification, especially in demanding neurobiology applications.

• EZ Cap Cy5 Firefly Luciferase mRNA: Workflow, Imaging, and L

  2026-07-31

  EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) empowers precise, real-time visualization of mRNA delivery and expression, coupling dual-mode detection with enhanced immune evasion. This guide details experimental best practices, advanced lipid nanoparticle (LNP) workflows, and troubleshooting strategies for optimal performance in translation efficiency and high-throughput screening.

• Viral Degradation of RIPK3: A Mechanism Regulating Necroptos

  2026-07-31

  Liu et al. identify a class of orthopoxvirus proteins that trigger ubiquitin-proteasome-mediated degradation of RIPK3, thereby suppressing necroptosis and modulating virus-induced inflammation. The study reveals a novel viral immune evasion strategy with broad implications for understanding host-pathogen interactions and the role of protein degradation machinery in innate immunity.

• Aminopeptidase Inhibition Alters Angiotensin Activity in Rat

  2026-07-30

  This study demonstrates that Bestatin hydrochloride (Ubenimex) selectively enhances angiotensin II and III-evoked neuronal activity in the rat brain by inhibiting aminopeptidase B. The findings provide mechanistic insights into angiotensin peptide processing and suggest new research avenues for aminopeptidase inhibitors in neuropeptide signaling.

• Lypressin Acetate: Optimizing Experimental Workflows in Vaso

  2026-07-30

  Lypressin acetate is a versatile vasopressin analog distinguished by its robust activity in GPCR signaling, antidiuretic modeling, and emerging antiviral research. This guide details stepwise workflows, practical troubleshooting, and cross-domain assay enhancements that leverage APExBIO’s lypressin acetate for reproducible, translational results.

• Dextromethorphan Hydrobromide: Optimizing NMDA Antagonist Wo

  2026-07-29

  Dextromethorphan hydrobromide stands out in neuroprotection research as a high-purity NMDA receptor antagonist, enabling precise modulation of excitotoxicity in both in vitro and in vivo models. This guide delivers actionable protocol enhancements, troubleshooting insights, and a deep dive into comparative advantages for neuroscience workflows.

• Capsazepine Targets MCL1 to Overcome Tamoxifen Resistance in

  2026-07-29

  This article examines a recent study that identifies capsazepine as a novel MCL1 inhibitor capable of reversing tamoxifen resistance in estrogen receptor-positive breast cancer. The findings highlight the value of structure-based virtual screening and mechanistic validation in developing strategies to target anti-apoptotic proteins implicated in drug resistance.

• Crizotinib Hydrochloride: Engineering Tumor Microenvironment

  2026-07-28

  Explore how Crizotinib hydrochloride, a potent ALK kinase inhibitor, is revolutionizing the study of tumor–stroma interactions in physiologically relevant gastric cancer models. This article uniquely focuses on rational assay design, stromal modulation, and translational implications for advanced cancer biology research.

• SM-164: Bivalent Smac Mimetic Workflows for Apoptosis Assays

  2026-07-28

  SM-164 is redefining apoptosis induction in cancer research with rapid, high-affinity inhibition of IAPs and robust TNFα-dependent tumor cell killing. This guide delivers advanced workflows, troubleshooting strategies, and translational insights to maximize reproducibility and sensitivity when using SM-164 from APExBIO.

• Staurosporine in Precision Apoptosis Modeling: Protocol Adva

  2026-07-27

  Discover how Staurosporine, a broad-spectrum serine/threonine protein kinase inhibitor, enables next-generation quantification of apoptosis in cancer cell lines. This article uniquely bridges technical assay optimization and the latest high-throughput microscopy insights for advanced cancer research.

• Blocking GCLC Truncation Delays Cataract Formation via GSH P

  2026-07-27

  Wei et al. (2024) elucidate how age-related truncation of the γ-glutamylcysteine ligase catalytic subunit (GCLC) at D499 accelerates glutathione (GSH) depletion and cataract formation. Preventing this truncation in a knock-in mouse model preserves lens GSH, markedly delaying cataracts, thus highlighting a molecular target for future preventative strategies.

• Apigenin for Oncology & Neuroprotection: Protocols and Insig

  2026-07-26

  Apigenin (5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one) stands out as a dual-purpose research tool for malignant mesothelioma and Alzheimer's disease models. Discover evidence-based protocols, troubleshooting strategies, and the latest workflow enhancements that make APExBIO's Apigenin the preferred choice for cancer and neuroprotection studies.

16302 records 1/1087 page Next 12345 下5页 Last page